Organogenesis holdings inc. (ORGO)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Dec'15
ASSETS
Current assets:
Cash

46,898

60,174

22,974

20,040

30,561

21,291

2

64

99

2,309

117

286

486

1,040

171

126

Restricted cash

176

196

185

119

102

114

-

-

-

49

-

-

-

-

-

-

Accounts receivable, net

32,724

39,359

34,383

34,157

32,509

34,077

-

-

-

28,124

-

-

-

-

-

-

Inventory

26,436

22,918

20,184

18,717

17,972

13,321

-

-

-

14,270

-

-

-

-

-

-

Prepaid expenses and other current assets

5,164

2,953

3,117

3,113

3,918

2,328

-

-

-

4,399

-

-

-

-

-

-

Contingent consideration forfeiture rights

-

-

-

-

-

-

-

-

-

589

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

22

96

169

-

242

316

393

395

-

-

Total current assets

111,398

125,600

80,843

76,146

85,062

71,131

25

160

269

49,740

360

602

879

1,435

-

126

Property and equipment, net

50,071

47,184

44,254

40,751

39,454

39,623

-

-

-

42,112

-

-

-

-

-

-

Notes receivable from related parties

576

556

536

516

496

477

-

-

-

413

-

-

-

-

-

-

Intangible assets, net

19,981

20,797

22,314

23,844

24,592

26,091

-

-

-

29,759

-

-

-

-

-

-

Goodwill

25,539

25,539

25,539

25,539

25,539

25,539

-

-

-

25,539

-

-

-

-

-

-

Deferred tax asset

15

127

238

238

238

238

-

-

-

424

-

-

-

-

-

-

Other assets

760

884

916

1,040

1,072

579

-

-

-

735

-

-

-

-

-

-

Cash and cash equivalents held in Trust Account

-

-

-

-

-

-

316,284

314,820

313,202

-

311,658

310,375

310,000

310,000

-

-

Accrued interest receivable held in Trust Account

-

-

-

-

-

-

-

-

318

-

39

586

359

-

-

-

Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

650

-

Total assets

208,340

220,687

174,640

168,074

176,453

163,678

316,309

314,981

313,790

148,722

312,057

311,564

311,239

311,435

821

416

Liabilities and Stockholders' Equity
Current liabilities:
Deferred acquisition consideration

1,958

5,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of term loan

1,667

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred acquisition consideration

-

-

5,000

5,000

5,000

5,000

-

-

-

5,000

-

-

-

-

-

-

Redeemable common stock liability

-

-

-

-

-

6,762

-

-

-

-

-

-

-

-

-

-

Current portion of notes payable

-

-

-

-

-

2,545

-

-

-

0

-

-

-

-

-

-

Current portion of capital lease obligations

3,189

3,057

2,872

2,442

2,337

2,236

-

-

-

5,369

-

-

-

-

-

-

Accounts payable

26,208

28,387

28,251

22,278

24,575

19,165

-

-

-

19,053

-

-

-

-

-

-

Accrued expenses and other current liabilities

21,803

23,450

20,606

20,679

20,395

20,388

-

-

-

22,551

-

-

-

-

-

-

Offering costs payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

538

232

Note payable to Sponsor

-

-

-

-

-

-

700

475

300

-

-

-

-

-

300

-

Accrued expenses

-

-

-

-

-

-

7,309

5,421

4,762

-

2,696

85

140

50

14

8

Total current liabilities

54,825

59,894

56,729

50,399

52,307

56,096

8,009

5,896

5,062

51,973

2,696

85

140

478

852

416

Line of credit

33,484

33,484

33,484

33,484

30,984

26,484

-

-

-

17,618

-

-

-

-

-

-

Notes payable, net of current portion

-

-

-

-

-

12,578

-

-

-

14,816

-

-

-

-

-

-

Term loan

57,910

49,634

49,599

39,662

39,635

0

-

-

-

52,142

-

-

-

-

-

-

Due to affiliates

-

-

-

-

-

-

-

-

-

4,500

-

-

-

-

-

-

Warrant liability

-

-

-

-

-

-

-

-

-

2,238

-

-

-

-

-

-

Deferred rent

1,105

1,012

736

456

179

130

-

-

-

74

-

-

-

-

-

-

Capital lease obligations, net of current portion

13,755

14,431

14,893

14,655

15,109

15,418

-

-

-

12,390

-

-

-

-

-

-

Other liabilities

6,966

6,649

6,391

6,220

5,680

5,931

-

-

-

1,526

-

-

-

-

-

-

Deferred underwriting commission

-

-

-

-

-

-

5,128

10,850

10,850

-

10,850

10,850

10,850

10,850

-

-

Total liabilities

168,045

165,104

161,832

144,876

143,894

116,637

13,137

16,746

15,912

157,277

13,546

10,935

10,990

11,328

-

416

Commitments and contingencies (Note 13)

-

-

-

-

-

-

0

0

0

-

0

-

0

0

0

0

Redeemable common stock, $0.0001 par value; 728,549 shares issued and outstanding at December 31, 2018 and 2017.

-

-

-

-

-

-

298,171

293,234

292,877

6,762

293,511

295,628

295,248

295,107

-

-

Stockholders' equity (deficit):
Preferred shares, $0.0001 par value, 1,000,000 shares authorized: no shares issued and outstanding at September 30, 2018 and December 31, 2017

-

-

-

-

-

-

0

0

0

-

-

-

0

0

0

-

Common stock, $0.0001 par value; 400,000,000 shares authorized; 106,088,563 and 105,599,434 shares issued; 105,360,015 and 104,870,886 shares outstanding at March 31, 2020 and December 31, 2019, respectively.

11

10

9

9

9

9

-

-

-

6

-

-

-

-

-

-

Additional paid-in capital

227,604

226,580

179,408

178,412

178,124

177,272

2,169

7,105

7,462

50,086

6,828

4,711

5,092

5,232

24

24

Accumulated deficit

-187,320

-171,007

-166,609

-155,223

-145,574

-130,240

2,829

-2,106

-2,463

-65,409

-1,829

287

-92

-233

-55

-25

Total stockholders' equity

40,295

55,583

12,808

23,198

32,559

47,041

5,000

5,000

5,000

-15,317

5,000

5,000

5,000

5,000

-30

-0

Total liabilities and stockholders' equity

208,340

220,687

174,640

168,074

176,453

163,678

316,309

314,981

313,790

148,722

312,057

311,564

311,239

311,435

821

416